Mild COVID-19 symptoms despite treatment with teriflunomide and high-dose methylprednisolone due to multiple sclerosis relapse

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology 2020-10, Vol.267 (10), p.2803-2805
Hauptverfasser:	Möhn, Nora, Saker, Firas, Bonda, Viktoria, Respondek, Gesine, Bachmann, Marcus, Stoll, Matthias, Wattjes, Mike P., Stangel, Martin, Skripuletz, Thomas
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Anti-Inflammatory Agents - therapeutic use Betacoronavirus Coronavirus Infections - complications COVID-19 Crotonates - therapeutic use Humans Hydroxybutyrates Letter to the Editors Male Medicine Medicine & Public Health Methylprednisolone Methylprednisolone - therapeutic use Multiple sclerosis Multiple Sclerosis, Relapsing-Remitting - complications Multiple Sclerosis, Relapsing-Remitting - drug therapy Neurology Neuroradiology Neurosciences Nitriles Pandemics Pneumonia, Viral - complications Recurrence SARS-CoV-2 Toluidines - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!